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The presence of pre-existing morbidities poses a challenge to cancer patient care. There is little 
information on the profile and prevalence of multi-morbidities in breast cancer patients across 
middle to lower income countries (MIC and LIC) in Sub-Saharan Africa (SSA). The African 
Breast Cancer–Disparities in Outcomes breast cancer cohort spans upper MICs South Africa 
and Namibia, lower MICs Zambia and Nigeria and LIC Uganda. At cancer diagnosis 7 
morbidities were assessed: obesity, hypertension, diabetes, asthma/chronic obstructive 
pulmonary disease, heart disease, tuberculosis and HIV. Logistic regression models were used 
to assess determinants of morbidities and the influence of morbidities on advanced stage (stage 
III/IV) breast cancer diagnosis. Among 2189 women, morbidity prevalence was highest for 
obesity (35%, country-specific range 15-57%), hypertension (32%, 15-51%) and HIV (16%, 
2-26%) then for diabetes (7%, 4-10%), asthma (4%, 2-10%), tuberculosis (4%, 0-8%) and heart 
disease (3%, 1-7%). Obesity and hypertension were more common in upper MICs and in higher 
socio-economic groups. Overall, 27% of women had at least 2 pre-existing morbidities. Older 
women were more likely to have obesity (odds ratio: 1.09 per 10 years, 95% CI 1.01-1.18), 
hypertension (1.98, 1.81-2.17), diabetes (1.51, 1.32-1.74) and heart disease (1.69, 1.37-2.09) 
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and were less likely to be HIV positive (0.64, 0.58-0.71). Multi-morbidity was not associated 
with stage-at-diagnosis, with the exception of earlier stage in obese and hypertensive women. 
Breast cancer patients in higher income countries and higher social groups in SSA face the 
additional burden of pre-existing non-communicable diseases, particularly obesity and 
hypertension, exacerbated by HIV in Southern/Eastern Africa. 
  
Keywords: Breast cancer, chronic condition, multi-morbidity, stage at diagnosis and sub-
Saharan Africa 
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Novelty and impact statement 
“Pre-existing morbidities in women with breast cancer poses a challenge to patient care. This 
study shows the prevalence and patterns of chronic conditions and multi-morbidity in women 
newly diagnosed with breast cancer in five SSA countries in different stages of economic, 
developmental and lifestyle transition. Obesity and hypertension are more common in higher 
social groups and associated with early stage breast cancer diagnosis. The burden of pre-
existing multi-morbidities among breast cancer patients in SSA is substantial and is 





Breast cancer is the most common malignancy and the leading cause of cancer mortality in 
women worldwide. It is also the most common cancer among women in sub-Saharan Africa 
(SSA)1 where the incidence of this cancer is on the rise. These temporal changes form part of 
an epidemiological transition occurring in SSA, characterized by improved control of 
infectious diseases, ageing populations and increasing prevalence of risk factors for non-
communicable diseases (NCD) due to economic advancement, urbanisation and lifestyle 
modifications.2 These syndemics also result in multi-morbidity (the co-occurrence of two or 
more chronic comorbidities in one person)3 at the individual level, including in breast cancer 
patients. 
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Survival after breast cancer diagnosis is determined by patient characteristics and disease-
related factors such as stage at diagnosis and breast cancer subtypes.4 In addition to these 
factors, studies mostly originating from high-income countries (HICs) have shown that several 
pre-existing morbidities are associated with lower breast cancer survival, poorer overall 
outcomes and they also impact on treatment recommendations and tolerance.5, 6 These 
morbidities include obesity, diabetes and insulin resistance, stroke, body composition and 
mental health illnesses, i.e. conditions which tend to be more common in older breast cancer 
patients.7 
Pre-existing chronic conditions have also been linked to stage at cancer diagnosis, but the 
direction, degree and mechanisms of associations have not been consistent.8-10 The presence of 
pre-existing morbidities have been linked to increased risk of metastatic disease at diagnosis8, 
whereas links to earlier stage at diagnosis have been reported in settings served by population-
based breast cancer screening.11 Some studies also noted earlier stage at diagnosis in women 
with hypertension9, 12, possibly arising from a ‘surveillance effect’ (i.e. greater clinical scrutiny 
upon follow-up for hypertension/ greater opportunity to seek help during health system 
contacts for other illnesses). 
In the SSA setting, there is a paucity of data on the profile of pre-existing morbidity profiles 
among breast cancer patients. Such profiles are likely to differ across SSA countries at differing 
stages of economic, developmental and lifestyle transitions, i.e. different in SSA middle 
income countries (MICs) from low income countries (LICs).13, 14 Further, in addition to the 
aforementioned conditions, the setting-pertinent infectious disease of HIV needs to be taken 
into account, due to the ageing HIV-positive population successfully treated with antiretroviral 
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drugs.15 Establishing these SSA-specific morbidity profiles of breast cancer patients will form 
a first step to inform priorities for feasible management strategies in constrained public health 
systems. 
To date, we have investigated this morbidity profile among breast cancer patients diagnosed at 
five hospitals in South Africa and found that 44% of women had pre-existing morbidities at 
diagnosis: 53% were obese, 41% hypertensive, 22% HIV-positive and 14% were diabetic. 
Multi-morbidities were linked to older age and higher socioeconomic status.12 In the present 
study, we broadened our perspective to five SSA countries, including the upper MICs of South 
Africa and Namibia, lower MICs of Zambia and Nigeria and LIC of Uganda. Our aims were 
three-fold: (i) to describe the prevalence and profile of pre-existing chronic conditions and 
multi-morbidity (at least two chronic conditions in addition to breast cancer) in women newly 
diagnosed with breast cancer in 5 countries in SSA; (ii) to determine the socio-demographic 
factors associated with individual chronic conditions and multimorbidity and (iii) to assess 
whether any of the individual chronic conditions or multimorbidity was associated with breast 
cancer stage at diagnosis.  
 
METHODS 
Study design and study setting 
Presence of pre-existing chronic conditions and multi-morbidity in women newly diagnosed 
with breast cancer was examined within the African Breast Cancer-Disparities in Outcomes 
study (ABC-DO) cohort, a prospective multi-country hospital based breast cancer cohort in 
Southern (South Africa, Namibia and Zambia), Western (Nigeria) and Eastern (Uganda) SSA 
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countries.16 Incident breast cancer patients were recruited at Windhoek Central Hospital, 
Namibia; Abia State University Teaching Hospital and the Maranatha private clinic, Aba and 
the Federal Medical Centre, Owerri, Nigeria; Chris Hani Baragwanath Academic hospital, 
Soweto, South Africa; Mulago Hospital and the Uganda Cancer Institute, Kampala, Uganda; 
and the Cancer Diseases Hospital and University Teaching Hospital, Lusaka, Zambia. The 
ABC-DO protocol was previously published.16  
Participants 
Recruitment commenced from September through December 2014 in most centres and was 
completed by April 2017 except in Zambia (May 2016 through September 2017).  Women ≥18 
years of age with a clinically/histologically confirmed newly diagnosed breast cancer who 
provided written consent to participate in the study, and provided access to their medical 
records and tumour tissue were enrolled. ABC-DO was approved by ethics committees at each 
recruitment institution: IARC (IEC 13–19, IEC15–18), the London School of Hygiene and 
Tropical Medicine (6459), University of Witwatersrand, South Africa (M150345), Council for 
Science and Technology (HS 1588) and the Ministry of Health and Social Services of Namibia 
(17/3/3), University of Zambia Biomedical Research Ethics Committee (004-08-15), Federal 
Medical Centre Owerri, Abia State University Teaching Hospital and Uganda National Council 
for Science and Technology (HS 1588). This study was performed in accordance with the 
Declaration of Helsinki. 
The present analyses of pre-existing morbidities were conducted overall and by site-race group, 
with Namibian women separated into black and non-black ethnic groups as these groups were 
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different in socio-economic profile and stage distribution.17 Participants from other countries 
were almost exclusively black women, forty two non-black South Africans were excluded from 
the analysis as this group was too small to analyse separately. 
Exposure and outcome data 
The same face-to-face baseline questionnaire was utilized in all hospitals except in South 
Africa where a pre-existing survey instrument was administered and harmonized to ABC-DO 
specifications. For this analysis we included questions on age, self-identified ethnic group, and 
marital status. Educational level was categorised as primary education or none and secondary 
education or higher. We grouped employment into 2 categories, employed (highly 
skilled/skilled, employed in South Africa) versus unemployed (unskilled, unemployed and 
retired in South Africa). A score for socioeconomic position (SEP) was generated from self-
reported household facilities and possessions: home ownership, flush toilet, indoor running 
water, vehicle, electricity, gas or electric stove, refrigerator,  landline phone and a bed. A score 
of +1 was allocated to each possession ranging from 0 (low) to 9 (high). 
We examined the presence of seven chronic conditions: obesity, hypertension, diabetes, heart 
disease, asthma/chronic obstructive pulmonary disease (COPD), HIV infection and 
tuberculosis. The 7 conditions were included because of their known association with breast 
cancer prognosis (obesity18, diabetes19, HIV4), their known impact on treatment (e.g. 
cardiotoxicity and worsening of hypertension20) and/or their known high prevalence in the least 
parts of SSA where regular treatment may provide an avenue for early cancer detection (e.g. 
HIV and tuberculosis21, COPD22, hypertension and heart disease23). Body weight and height 
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were measured at enrolment, and obesity was defined as a body mass index (BMI) ≥30.0 kg/m². 
Patients were asked if they had ever been treated for tuberculosis and whether they had ever 
been diagnosed and treated with hypertension, diabetes, heart disease, asthma/COPD 
(Questionnaire on chronic conditions collected provided as supplementary material, page 5). 
HIV infection (yes vs. no/not known) was based on self-reports, with 90% of the cohort (apart 
from South Africa) reporting the later, however there was a 97% agreement with clinical 
records among those reported negative. In South Africa HIV status was tested as part of the 
diagnostic workup, using the enzyme-linked immunosorbent assay by the National Health 
Laboratory Services. We defined multi-morbidity as having ≥ 2 of these seven chronic 
conditions, in addition to breast cancer.  
Breast cancer stage at diagnosis was determined using the American Joint Committee on 
Cancer (AJCC) TNM staging system24 and categorized for analyses as early (stages I & II) and 
advanced (stages III & IV). 
Statistical methods 
We described the pattern and prevalence of each chronic condition by site-race group using 
Pearson’s chi squared and Fishers Exact tests. We examined associations of socio-demographic 
factors with each chronic condition and with multi-morbidity (≥ 2 of these chronic conditions 
in addition to the breast cancer) using logistic regression analysis. Logistic regression was also 
used to examine whether each chronic condition and multi-morbidity were associated with 
advanced stage breast cancer (stages III & IV), as compared to early stage breast cancer (stages 
I & II). Variables for which p values were <0.1 in bivariate analysis with advanced stage breast 
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cancer were evaluated and ORs were assessed adjusting for each covariate, HIV status, age, 
and country (as a proxy for level of health care). Analysis was performed using Stata version 
15 (StataCorp Ltd, Texas, USA). 
 
RESULTS 
A total of 2189 women were included:  720 (33%) from South Africa, 478 (22%) (99 non-
black and 379 black) from Namibia, 187 (9%) from Zambia, 382 (17%) from Nigeria and 422 
(19%) from Uganda (Table 1). The mean age at diagnosis was 51.7±13.9, with women from 
Zambia, Nigeria and Uganda (range of mean age 48.4 – 49.4 years) significantly younger than 
women from Namibia and South Africa (range of mean age 52.5 - 57.1 years). Overall 62% of 
the women had at least secondary school education with the non-black Namibian (87%), South 
African (77%) and Nigerian (72%) women more likely to have had at least secondary education 
compared to black Namibian (49%), Zambian (47%) and Ugandan (42%) women. In keeping 
with these low and middle income (LMIC) settings, most women had low to medium SEP with 
higher SEP in non-black Namibia women. Smoking prevalence was low, ranging from < 1% 
in Nigeria to 43% among the non-black Namibian women. Approximately 59% of the women 
presented with advanced stage breast cancer overall (50% in South Africa to 75% in Nigeria), 
with the exception of non-black Namibian women where the majority presented with early 
stage disease (78%) (Table1). 
 
Prevalence of chronic conditions and multi-morbidity 
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Hypertension and obesity dominated as the most common chronic conditions in breast cancer 
patients in each country, with hypertension ranking first in all countries except in South Africa 
where obesity ranked as the most common pre-existing chronic condition. HIV ranked 3rd 
prevalent in all countries except in non-black Namibians (where asthma/COPD was in 3rd rank) 
and in Nigeria (diabetes ranked 3rd). Diabetes was the fourth most prevalent chronic condition 
in most countries except among the black Namibian women (tuberculosis was 4th) and in 
Nigeria (heart disease was 4th) (Table 2). Overall South Africa had the highest prevalence of 
HIV in the whole cohort (26%) (Table 2) with 42% of the women <50 years of age infected 
with HIV (Figure 1).  
Twenty seven percent of the women newly diagnosed with breast cancer presented with multi-
morbidity (presence of ≥2 additional chronic conditions) ranging from 42% in South Africa to 
11% in Uganda (Table 2). Percentages of women with multi-morbidity was highest in South 
African women both under and over age 50, with 49% of the women ≥50 years presenting with 
multi-morbidity in addition to breast cancer. Women from lower MICs Zambia and Nigeria 
and LIC Uganda had the least prevalence of multi-morbidity in both age groups (Figure 1). 
With 7 conditions included, of a possible 128 (27) morbidity combinations, 57 combinations 
were present among the 2189 women and only 16 combinations were present in at least 5 
women. The profile and prevalence of these combinations for the 11 most common 
combinations in each population group is shown in Figure 2 (i.e. no pre-existing morbidities 
and ten combinations with at least one pre-existing morbidities). Where multi-morbidity was 
present, obesity and hypertension was the dominant combination, affecting 15% of Namibian 
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non-black and 14% of South African women. The only other combination affecting at least 5% 
of breast cancer patients in a given group was obesity and HIV in South Africa. 
 
Determinants of chronic conditions 
Associations of socio-demographic factors with each chronic condition are presented in table 
3. In the mutually adjusted analysis of all countries combined, older women were significantly 
more likely to be obese, hypertensive, diabetic and have heart disease and less likely to be 
living with HIV. Of the three measures of socio-economic status, SEP was most frequently 
associated with the presence of a chronic condition. Women with higher SEP (7-9 (high) and 
4-6 (medium)) were more likely to be obese and diabetic compared with women with low SEP 
(0-3). High SEP women were also more likely to have hypertension compared to those with 
low SEP (OR: 1.89, 95% CI 1.33-2.59). Associations of age and SEP with the two 
communicable diseases, tuberculosis and HIV, tended to be in the opposite direction to those 
for the aforementioned NCDs. Notably, women with medium SEP were less likely to have HIV 
compared to the women with low SEP. Those employed were more likely to be obese while 
level of education was not significantly associated with any chronic condition except in Nigeria 
where those with secondary education and above were more likely to have heart disease (result 
not shown). 
Determinants of the presence of pre-existing multi-morbidities mirror the associations above, 
particularly for the NCDs, as the co-presence of obesity and hypertension was the most 
prevalent combinations. Adjusting for age and country site higher SEP compared to low SEP 
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was associated with greater risk for multi-morbidity at breast cancer diagnosis (Supplementary 
table 1). 
Influence of pre-existing morbidities on stage at diagnosis 
Among 2066 women with known stage at diagnosis, investigations of whether pre-existing 
morbidities affected stage at diagnosis are illustrated in Figure 3 for each site, and results of 
the ABC-DO wide pooled analysis are shown in table 4 and supplementary table 2. Most site-
specific associations were not significant or suggestive, with the following exceptions. 
Adjusting for age at diagnosis, obese women from Zambia (OR: 0.36, 95% CI 0.16-0.78) and 
hypertensive women from Nigeria (OR: 0.57, 95% CI 0.33-0.98) were less likely to be 
diagnosed with advanced stage breast cancer compared to their country-counterparts without 
these conditions. In contrast, among South African women, those women who had tuberculosis 
were more likely to be diagnosed with advanced stage breast cancer than those without such a 
history (OR: 1.91, 95% CI 1.02-3.57).  Nigeria, Zambian and Ugandan women who were HIV 
infected were more likely to be diagnosed with advanced stage breast cancer than their HIV-
negative counterparts, though these associations were not significant and were not present in 
all settings (Figure 3). 
Thus meta-analytic estimates across all population groups suggested no association of 
tuberculosis, asthma/COPD, diabetes and HIV with stage at diagnosis, consistent with the 
pooled analyses in Table 4. However for hypertension, in meta-analyses, there was a suggestion 
of a 17% (-3% to 33%) relative reduction in advanced stage breast cancer associated with 
having this condition, which increased to a 35% (1 to 55%) reduction in pooled analyses 
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adjusted for HIV.   Similarly for obesity, the meta-analysis was suggestive of 12% (95% CI -
8% to 28%) reduced odds of advanced stage at diagnosis, which became significant in pooled 
analyses (28% reduction (1 to 48%). Despite these individual conditions of obesity and 
hypertension being the most common multi-morbidity combination, the overall effect of multi-
morbidity on advanced stage at cancer diagnosis was borderline suggestive of a positive 
association (OR: 1.34, 95% CI 0.95-1.89) (Table 4). 
Discussion 
Summary of findings 
In this large cohort of breast cancer patients in five SSA countries, the prevalence of at least 
one of seven pre-existing chronic conditions (obesity, hypertension, diabetes, heart disease, 
asthma/COPD, HIV infection and tuberculosis) was high (65%) and 27% of women had at 
least two pre-existing chronic conditions (multi-morbidity). Obesity and hypertension were the 
two most frequent conditions present, both individually and as a combination amongst women 
with multi-morbidities, particularly affecting older women and groups with higher 
socioeconomic status both at the intra-country individual level and, reflecting epidemiologic 
transitions, at national levels. HIV ranked 3rd in most countries except in non-black Namibian 
women and in West African Nigeria. The management of breast cancer in SSA thus needs to 
consider this high percentage of NCDs, alone or in combination with HIV. Nevertheless, none 
of the seven chronic conditions investigated were positively associated with having advanced 
stage breast cancer at diagnosis, with the exception of obesity and hypertension which was 
associated with having early stage breast cancer. The latter findings points to an opportunity to 
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further increase early diagnosis, in an attempt to counterbalance any survival disadvantage 
among these women. 
Major prevalent chronic conditions: in the population as risk factors for breast cancer and 
impact on prognosis 
Multi-morbidity prevalence closely tracked the wealth index of the countries under 
investigation and the socioeconomic position scores of the women under investigation. Women 
from higher MICs with more advanced westernised lifestyle transitions had the greater multi-
morbidity burden (South Africa (42%) followed by Namibia) than those from lower middle 
income Zambia and Nigeria and low income Uganda. These findings were in keeping with 
ranges of 14% to 68% reported from other studies.12, 25, 26 With 27% of our patients presenting 
with multi-morbidity (≥2 chronic conditions), SSA is facing a significant challenge of multi-
morbidity comprising both infectious diseases combined with the rapidly growing NCD 
prevalence as countries transition to westernized lifestyles. Hypertension ranked as the most 
common chronic condition in most countries except in South Africa where obesity ranked first, 
ranging from 15% in LIC Uganda to 51% amongst MIC non-black Namibian women. 
Hypertension is a public health challenge in Africa with 46% of its population aged 25 years 
and over living with hypertension.27 Hypertension might be positively linked to risk of breast 
cancer especially in postmenopausal women28 hence its high prevalence among our women is 
particularly worrying. More critically, during the therapeutic phase, chemotherapy can worsen 
hypertension and cause cardiomyopathy.29  
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Obesity, a known risk factor for breast cancer in postmenopausal women,30 has also been 
associated with worse breast cancer outcomes for women of all ages.18 Obesity was commonly 
reported in this study though with high variation across countries in various stages of lifestyle 
transition. South Africa has the highest prevalence with 57% of the women obese while Uganda 
had the lowest prevalence (15%). The emerging prevalence of obesity in SSA has been largely 
attributed to the rising empowerment of women, sedentary lifestyles, economic development 
and urbanization31 ultimately leading to nutritional transition. Obesity at postmenopausal ages 
is a driver of increasing breast cancer incidence rates, thus in this instance the rising obesity 
rates are fuelling more cases with poorer prognosis. Diabetes with prevalence ranging from 4% 
in Uganda to 10% in South Africa is also a known risk factor for breast cancer in 
postmenopausal women,32 it is also associated with worse survival with up to an increased risk 
of 52% in overall mortality.33  
The high burden of HIV amongst particularly our southern African women in this study is of 
continued concern with HIV now regarded as a chronic infectious disease, though the general 
consensus is that there is no significant link between HIV and risk of breast cancer;34  however, 
studies have reported poorer prognosis in HIV positive patients with breast cancer.4, 35 
Determinants of chronic conditions 
As expected, most chronic conditions were more prevalent in older women, a finding consistent 
with previous studies in SSA.12, 36 We also found that women with higher SEP were more likely 
to present with obesity, hypertension and diabetes in contrast to findings from other mainly 
HIC studies where multimorbidity was more prevalent at lower SEP.26, 37, 38 However our 
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findings were consistent with other studies from LMICs for multimorbidity,25 
overweight/obesity, hypertension and diabetes.36 These findings perhaps reflects westernized 
lifestyle and dietary transitions first affecting higher SEP groups with the capital needed to 
purchase and live modern lifestyles.39  
Impact on stage 
It is known that advanced cancer stage at diagnosis is affected by chronic conditions,8-10 
however some studies have consistently demonstrated earlier stage at diagnosis with chronic 
conditions.11, 12, 40 In this study we found no significant association between multi-morbidity 
and advanced stage at breast cancer diagnosis. Women who had hypertension at diagnosis of 
breast cancer were more likely to have early stage breast cancer, perhaps due to their regular 
access to the health system facilities for other conditions.36, 37 Our patients that were obese were 
less likely to present with advanced stage breast cancer, this is in contrast to studies suggesting 
that higher BMI is associated with a more advanced stage of breast cancer at diagnosis.41, 42 
Our finding could be attributable to reverse causality given the 59% of late stage tumour in the 
cohort. 
Strengths and limitations 
This study benefitted from a diversity of countries across SSA, a wide range of morbidities 
included, a strong SSA-perspective on the selection of morbidities, heterogeneity in socio-
demographic factors, measured BMI, tested HIV in South Africa and a prospective design. 
However, the sample was tertiary hospital-based patients, and many breast cancer patients in 
SSA may never reach this level of the health system. Further limitations were noted: most of 
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these chronic conditions were self-reported, hence we could have underestimated the 
prevalence of multi-morbidity especially in women with lower SEP. In SSA, low 
socioeconomic status is associated with lower access to care and treatment43 and thus there 
could be lower rates of diagnosis of these chronic conditions in women with lower SEP. 
Implications on therapeutic management 
The implication of multi-morbidity in women with breast cancer is profound including the high 
cost of care44 and poor quality of life45. Breast cancer patients with multi-morbidity are less 
likely to receive surgery,46 less likely to receive adjuvant chemotherapy,47 more likely to 
receive a reduced dose and less likely to complete chemotherapy treatment when initiated,48 
and less likely to initiate timely radiotherapy after surgical treatment.49 Multi-morbidity may 
cause higher rates of adverse effects of treatment50 affecting overall goal of care. It has been 
associated with an increased risk of cardiotoxicity, immunosuppression during chemotherapy 
and radiotherapy for HIV positive women.51 Further, at the health system level, the 
management of multi-morbidity is much more complicated and demanding for the patients and 
the health system, requiring an integrated approach and long-term care.52 To effectively address 
these changing needs, countries in SSA require detailed surveillance on chronic condition 
trends to assist in developing models of care appropriate for LMICs. 
Conclusion 
There is a high prevalence of chronic conditions and multi-morbidity in our breast cancer 
patients and socio-demographic factors play a major role in its determinants in SSA. With 
increasing life expectancy, the rapidly increasing multi-morbidity burden in SSA is of great 
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concern for its under resourced health care services. SSA studies of the impact of these 
morbidities on survival and therapeutic management are needed.  
  
DECLARATIONS 
Ethics statement: ABC-DO was approved by ethics committees at each recruitment 
institution: IARC (IEC 13–19, IEC15–18), the London School of Hygiene and Tropical 
Medicine (6459), University of Witwatersrand, South Africa (M150345), Council for Science 
and Technology (HS 1588) and the Ministry of Health and Social Services of Namibia (17/3/3), 
University of Zambia Biomedical Research Ethics Committee (004-08-15), Federal Medical 
Centre Owerri, Abia State University Teaching Hospital and Uganda National Council for 
Science and Technology (HS 1588). All participants provided written informed consent. 
Data availability statement: Data for this study contain confidential patient information. The 
datasets analysed during the current study are available from the corresponding author on 
reasonable request. 
Competing interests: The authors declare that they have no conflict of interest 
Grant: Susan G. Komen for the Cure Foundation; Grant number: IIR 13264158; Grant 
sponsor: IARC. 
Funding: ABC-DO was supported by IARC, Susan. G. Komen (IIR 13264158, 
GSP18IARC001, GSP19IARC001 and as part of “Implementing breast cancer care efficiency 
in Zambia through specialized health provider training and m-health evaluation of patient 
This article is protected by copyright. All rights reserved.
 
 
outcomes” for the Zambian site). This work was also supported by (i) NIH grant (NCI 
1R01CA192627) http://grantome.com/grant/ NIH/R01-CA192627-01, and (ii) the Cancer 
Association of South Africa (CANSA) grant “Down-staging and improving survival of breast 
cancer in South Africa” http://www.cansa.org.za/downstaging-and-improving-survival-of-
breast-cancerin-sa-dr-herbert-cubasch (HC). SAN is supported by the DST-NRF Centre of 
Excellence in Human Development at the University of the Witwatersrand, Johannesburg, 
South Africa. 
The funders had no role in study design, data collection and analysis, decision to publish, or 
preparation of the manuscript. The Wits Health Consortium (PTY) Ltd provided support in the 
form of payroll administration of salaries from grant funds for authors OA, MJ, SAN, but did 
not have any additional role in the study design, data collection and analysis, decision to 
publish, or preparation of the manuscript.  
Disclaimer: Where authors are identified as personnel of the International Agency for 
Research on Cancer / World Health Organization, the authors alone are responsible for the 
views expressed in this article and they do not necessarily represent the decisions, policy or 
views of the International Agency for Research on Cancer / World Health Organization 
Authors' contributions 
Conceptualization: OAA, MJ, SAN, VAM 
Study design: JS, BOA, IdSS, VAM, 
Recruitments of participants: OAA, MJ, HC, MG, AZ, GP, CA, AA 
This article is protected by copyright. All rights reserved.
 
 
Formal analysis: OAA, MF, VAM 
Funding acquisition: JS, IdSS, VAM 
Writing first draft of the manuscript: OAA, VAM 
All authors contributed to the interpretation of the results and critically reviewed the first draft 
of the manuscript; they all read and approved the final version of the manuscript, and they all 
agreed to be accountable for all aspects of the work in ensuring that questions related to the 
accuracy or integrity of any part of the work are appropriately investigated and resolved. 
Acknowledgements: 
The authors thank the women who participated in this study. They also thank the dedicated 
team of study research assistants for their help and assistance with the study. 
 
  




 1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: 
GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A 
Cancer Journal for Clinicians 2018;68: 394-424. 
 2. Black E, Richmond R. Improving early detection of breast cancer in sub-Saharan Africa: why 
mammography may not be the way forward. Globalization and health 2019;15: 3. 
 3. The L. Making more of multimorbidity: an emerging priority. Lancet (London, England) 
2018;391: 1637. 
 4. McCormack V, McKenzie F, Foerster M, Zietsman A, Galukande M, Adisa C, Anele A, Parham 
G, Pinder LF, Cubasch H. Breast cancer survival and survival gap apportionment in sub-Saharan Africa 
(ABC-DO): a prospective cohort study. The Lancet Global Health 2020;8: e1203-e12. 
 5. Prados-Torres A, Calderón-Larranaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker 
M. Multimorbidity patterns: a systematic review. Journal of clinical epidemiology 2014;67: 254-66. 
 6. Hawfield A, Lovato J, Covington D, Kimmick G. Retrospective study of the effect of 
comorbidity on use of adjuvant chemotherapy in older women with breast cancer in a tertiary care 
setting. Critical reviews in oncology/hematology 2006;59: 250-5. 
 7. Nechuta S, Lu W, Zheng Y, Cai H, Bao PP, Gu K, Zheng W, Shu XO. Comorbidities and breast 
cancer survival: a report from the Shanghai Breast Cancer Survival Study. Breast cancer research and 
treatment 2013;139: 227-35. 
 8. Gurney J, Sarfati D, Stanley J. The impact of patient comorbidity on cancer stage at 
diagnosis. British Journal of Cancer 2015;113: 1375-80. 
 9. Fleming ST, Pursley HG, Newman B, Pavlov D, Chen K. Comorbidity as a predictor of stage 
of illness for patients with breast cancer. Medical care 2005;43: 132-40. 
 10. Griffiths RI, Gleeson ML, Valderas JM, Danese MD. Impact of undetected comorbidity on 
treatment and outcomes of breast cancer. Int J Breast Cancer 2014;2014: 970780. 
 11. Vaeth PA, Satariano WA, Ragland DR. Limiting comorbid conditions and breast cancer 
stage at diagnosis. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 
2000;55: M593-M600. 
 12. Ayeni OA, Norris SA, Joffe M, Cubasch H, Nietz S, Buccimazza I, Singh U, Čačala S, Stopforth 
L, Chen WC. The multimorbidity profile of South African women newly diagnosed with breast cancer. 
International journal of cancer 2019. 
 13. Geyer HS, Mosidi N. Differential demographic transitions for Women of different 
ethnicities in Gauteng, South Africa, 1996–2011. Regional Science Policy & Practice 2019;11: 159-71. 
 14. Defo BK. Demographic, epidemiological, and health transitions: are they relevant to 
population health patterns in Africa? Global health action 2014;7: 22443. 
 15. McCormack VA, Febvey-Combes O, Ginsburg O, Dos-Santos-Silva I. Breast cancer in 
women living with HIV: A first global estimate. Int J Cancer 2018;143: 2732-40. 
 16. McKenzie F, Zietsman A, Galukande M, Anele A, Adisa C, Cubasch H, Parham G, Anderson 
BO, Abedi-Ardekani B, Schuz J. African Breast Cancer—Disparities in Outcomes (ABC-DO): protocol of 
a multicountry mobile health prospective study of breast cancer survival in sub-Saharan Africa. BMJ 
open 2016;6: e011390. 
 17. McKenzie F, Zietsman A, Galukande M, Anele A, Adisa C, Parham G, Pinder L, Cubasch H, 
Joffe M, Kidaaga F. Drivers of advanced stage at breast cancer diagnosis in the multicountry A frican 
This article is protected by copyright. All rights reserved.
 
 
breast cancer–disparities in outcomes (ABC-DO) study. International journal of cancer 2018;142: 1568-
79. 
 18. Kamineni A, Anderson ML, White E, Taplin SH, Porter P, Ballard-Barbash R, Malone K, Buist 
DS. Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast 
cancer in a mammographically screened population. Cancer Causes & Control 2013;24: 305-12. 
 19. Charlot M, Castro-Webb N, Bethea TN, Bertrand K, Boggs DA, Denis GV, Adams-Campbell 
LL, Rosenberg L, Palmer JR. Diabetes and breast cancer mortality in Black women. Cancer Causes & 
Control 2017;28: 61-7. 
 20. Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, Dent S, Kondapalli L, 
Ky B, Okwuosa T. Cardiovascular disease and breast cancer: where these entities intersect: a scientific 
statement from the American Heart Association. Circulation 2018;137: e30-e66. 
 21. Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, Chimzizi R, Harrington M, 
Maher D, Williams BG, De Cock KM. The HIV-associated tuberculosis epidemic—when will we act? The 
Lancet 2010;375: 1906-19. 
 22. Salvi S. The silent epidemic of COPD in Africa. The Lancet Global Health 2015;3: e6-e7. 
 23. Cappuccio FP, Miller MA. Cardiovascular disease and hypertension in sub-Saharan Africa: 
burden, risk and interventions. Internal and Emergency Medicine 2016;11: 299-305. 
 24. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress 
DM, Byrd DR, Winchester DP. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a 
bridge from a population-based to a more “personalized” approach to cancer staging. CA: A Cancer 
Journal for Clinicians 2017;67: 93-9. 
 25. Khanam MA, Streatfield PK, Kabir ZN, Qiu C, Cornelius C, Wahlin Å. Prevalence and 
patterns of multimorbidity among elderly people in rural Bangladesh: a cross-sectional study. J Health 
Popul Nutr 2011;29: 406. 
 26. Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, Glynn L, Muth 
C, Valderas JM. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic 
review of observational studies. PLoS One 2014;9: e102149. 
 27. Dzudie A, Rayner B, Ojji D, Schutte AE, Twagirumukiza M, Damasceno A, Ba SA, Kane A, 
Kramoh E, Kacou JBA. Roadmap to achieve 25% hypertension control in Africa by 2025. Global heart 
2018;13: 45-59. 
 28. Han H, Guo W, Shi W, Yu Y, Zhang Y, Ye X, He J. Hypertension and breast cancer risk: a 
systematic review and meta-analysis. Sci Rep 2017;7: 44877. 
 29. Izzedine H, Ederhy S, Goldwasser F, Soria J, Milano G, Cohen A, Khayat D, Spano J. 
Management of hypertension in angiogenesis inhibitor-treated patients. Annals of oncology 2009;20: 
807-15. 
 30. Gravena AAF, Romeiro Lopes TC, Demitto MO, Borghesan DHP, Dell' Agnolo CM, 
Brischiliari SCR, Carvalho MDB, Pelloso SM. The Obesity and the Risk of Breast Cancer among Pre and 
Postmenopausal Women. Asian Pac J Cancer Prev 2018;19: 2429-36. 
 31. Biadgilign S, Mgutshini T, Haile D, Gebremichael B, Moges Y, Tilahun K. Epidemiology of 
obesity and overweight in sub-Saharan Africa: a protocol for a systematic review and meta-analysis. 
BMJ open 2017;7: e017666. 
 32. Hardefeldt PJ, Edirimanne S, Eslick GD. Diabetes increases the risk of breast cancer: a meta-
analysis 2012;19: 793. 
 33. Zhao X-B, Ren G-S. Diabetes mellitus and prognosis in women with breast cancer: A 
systematic review and meta-analysis. Medicine 2016;95. 
This article is protected by copyright. All rights reserved.
 
 
 34. Spano JP, Lanoy E, Mounier N, Katlama C, Costagliola D, Heard I. Breast cancer among HIV 
infected individuals from the ONCOVIH study, in France: therapeutic implications. Eur J Cancer 
2012;48: 3335-41. 
 35. Coghill AE, Suneja G, Rositch AF, Shiels MS, Engels EA. HIV Infection, Cancer Treatment 
Regimens, and Cancer Outcomes Among Elderly Adults in the United States. JAMA oncology 2019;5. 
 36. Price AJ, Crampin AC, Amberbir A, Kayuni-Chihana N, Musicha C, Tafatatha T, Branson K, 
Lawlor DA, Mwaiyeghele E, Nkhwazi L, Smeeth L, Pearce N, et al. Prevalence of obesity, hypertension, 
and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in 
rural and urban Malawi. The Lancet Diabetes & Endocrinology 2018;6: 208-22. 
 37. Jackson CA, Dobson A, Tooth L, Mishra GD. Body mass index and socioeconomic position 
are associated with 9-year trajectories of multimorbidity: A population-based study. Preventive 
medicine 2015;81: 92-8. 
 38. Pathirana TI, Jackson CA. Socioeconomic status and multimorbidity: a systematic review 
and meta-analysis. Australian and New Zealand journal of public health 2018;42: 186-94. 
 39. Jacobs I, Taljaard-Krugell C, Ricci C, Vorster H, Rinaldi S, Cubasch H, Laubscher R, Joffe M, 
van Zyl T, Norris SA, Romieu I. Dietary intake and breast cancer risk in black South African women: the 
South African Breast Cancer study. Br J Nutr 2019;121: 591-600. 
 40. Sogaard M, Thomsen RW, Bossen KS, Sorensen HT, Norgaard M. The impact of comorbidity 
on cancer survival: a review. Clinical epidemiology 2013;5: 3-29. 
 41. Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL. Body mass and stage 
of breast cancer at diagnosis. International journal of cancer 2002;98: 279-83. 
 42. Ayoub NM, Yaghan RJ, Abdo NM, Matalka, II, Akhu-Zaheya LM, Al-Mohtaseb AH. Impact 
of Obesity on Clinicopathologic Characteristics and Disease Prognosis in Pre- and Postmenopausal 
Breast Cancer Patients: A Retrospective Institutional Study. J Obes 2019;2019: 3820759. 
 43. Foerster M, Anderson BO, McKenzie F, Galukande M, Anele A, Adisa C, Zietsman A, Schuz 
J, dos Santos Silva I, McCormack V. Inequities in breast cancer treatment in sub-Saharan Africa: 
findings from a prospective multi-country observational study. Breast Cancer Research 2019;21: 93. 
 44. Picco L, Achilla E, Abdin E, Chong SA, Vaingankar JA, McCrone P, Chua HC, Heng D, Magadi 
H, Ng LL, Prince M, Subramaniam M. Economic burden of multimorbidity among older adults: impact 
on healthcare and societal costs. BMC Health Serv Res 2016;16: 173. 
 45. Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality 
of life in primary care: a systematic review. Health Qual Life Outcomes 2004;2: 51. 
 46. Bates T, Evans T, Lagord C, Monypenny I, Kearins O, Lawrence G. A population based study 
of variations in operation rates for breast cancer, of comorbidity and prognosis at diagnosis: failure to 
operate for early breast cancer in older women. European Journal of Surgical Oncology (EJSO) 2014;40: 
1230-6. 
 47. Lee L, Cheung WY, Atkinson E, Krzyzanowska MK. Impact of comorbidity on chemotherapy 
use and outcomes in solid tumors: a systematic review. Journal of Clinical Oncology 2011;29: 106-17. 
 48. O'Connor TL, Edge SB, Kossoff EB, Groman A, Wilding GE, Ademuyiwa FO, Levine EG, 
Watroba N, Ngamphaiboon N. Factors affecting the delivery of adjuvant/neoadjuvant chemotherapy 
in older women with breast cancer. Journal of Geriatric Oncology 2012;3: 320-8. 
 49. Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI. Delay in initiating 
adjuvant radiotherapy following breast conservation surgery and its impact on survival. International 
Journal of Radiation Oncology* Biology* Physics 2006;65: 1353-60. 
This article is protected by copyright. All rights reserved.
 
 
 50. Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. 
CA: a cancer journal for clinicians 2016;66: 337-50. 
 51. Ngidi S, Magula N, Sartorius B, Govender P, Madiba TE. Incidence of chemotherapy-
induced neutropenia in HIV-infected and uninfected patients with breast cancer receiving 
neoadjuvant chemotherapy. South African Medical Journal 2017;107: 595-601. 
 52. McPhail SM. Multimorbidity in chronic disease: impact on health care resources and costs. 
Risk Manag Healthc Policy 2016;9: 143-56. 
 
  
This article is protected by copyright. All rights reserved.
 
 
Figure 1: The prevalence of pre-existing chronic conditions at breast cancer diagnosis in the 
ABC-DO study, overall and by age at cancer diagnosis. Multimorbidity prevalence indicates the 
presence of two or more of the seven pre-existing chronic condition at the time of breast cancer 
diagnosis.  
 
Figure 2: Profile of the combination of seven pre-existing morbidities amongst breast cancer 
patients in the ABC-DO study. 
 
Figure 3: Odds ratios of women being diagnosed with advanced stage breast cancer (stages III 
& IV) associated with each of the seven chronic conditions examined, by sub-Saharan Africa 
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Table 1: Characteristics of women newly diagnosed with breast cancer in Sub-Saharan Africa, by country and race; ABC-DO study. 
  
Southern Africa (S.A.) West Africa East Africa 
 
 
South Africa Namibia Non-
Black 
Namibia Black Zambia Nigeria Uganda Total 
 
N=720 (%) N=99 (%) N=379 (%) N=187 (%) N=382 (%) N=422 (%) N=2189 (%) 
Age in years, mean ± SD 54.5±14.3 57.1±12.4 52.5±14.6 49.4±14.2 48.8±12.2 48.4±12.6 51.7±13.9 
BMI (kg/m2) 31.7±7.7 29.1±6.8 26.4±6.7 26.5±6.3 26.4±5.7 25.6±4.6 28.1±7.0 
Marital status 
       
Married 233 (32.4) 58 (58.6) 122 (32.2) 110 (58.8) 250 (65.4) 199 (47.2) 972 (44.4) 
Not married 487 (67.6) 41 (41.4) 257 (67.8) 77 (41.2) 132 (34.6) 223 (52.8) 1217 (55.6) 
Received secondary education 
       
Yes 551 (76.5) 86 (86.9) 184 (48.5) 87 (46.5) 276 (72.3) 178 (42.2) 1362 (62.2) 
No 169 (23.5) 13 (13.1) 195 (51.5) 100 (53.5) 106 (27.7) 244 (57.8) 827 (37.8) 
Employment status 
       
Employed 202 (28.1) 98 (99.0) 346 (91.3) 73 (39.0) 357 (93.5) 331 (78.4) 1407 (64.3) 
Unemployed 518 (71.9) 1 (1.0) 33 (8.7) 114 (61.0) 25 (6.5) 91 (21.6) 782 (35.7) 
SEP 
       
Low (0-3) 273 (37.9) 0 (0.0) 166 (43.8) 67 (35.8) 161 (42.1) 249 (59.0) 916 (41.8) 
Medium (4-6) 433 (60.1) 39 (39.4) 130 (34.3) 69 (36.9) 167 (43.7) 90 (21.3) 928 (42.4) 
High (7-9) 14 (1.9) 60 (60.6) 83 (21.9) 51 (27.3) 54 (14.1) 83 (19.7) 345 (15.8) 
Ever consumed alcohol? 
       
No 565 (78.5) 37 (37.4) 185 (48.8) 123 (65.8) 178 (46.6) 225 (53.3) 1313 (60) 
Yes 155 (21.5) 62 (62.6) 194 (51.2) 64 (34.2) 204 (53.4) 197 (46.7) 876 (40) 
Ever smoked? 
       
No 677 (94.0) 56 (56.6) 324 (85.5) 185 (98.9) 381 (99.7) 408 (96.7) 2031 (92.8) 
Yes 43 (6.0) 43 (43.4) 55 (14.5) 2 (1.1) 1 (0.3) 14 (3.3) 158 (7.2) 
Stage at diagnosis 
       
Stage I & II 347 (49.6) 77 (77.8) 139 (36.7) 60 (40.3) 88 (25.1) 142 (36.5) 853 (41.3) 
Stage III `& IV 353 (50.4) 22 (22.2) 240 (63.3) 89 (59.7) 262 (74.9) 247 (63.5) 1213 (58.7) 






Table 2: Prevalence of pre-existing chronic conditions in women newly diagnosed with breast cancer in Sub-Saharan Africa, by country-site; ABC-
DO study. 
  
Southern Africa (S.A.) Upper MICs S.A. Lower MIC West Africa 
Lower MIC 
East Africa LIC 
 
 
South Africa Namibia Non-
Black 
Namibia Black Zambia Nigeria Uganda Total 
Ranked chronic conditions N=720 (%) N=99 (%) N=379 (%) N=187 (%) N=382 (%) N=422 (%) N=2189 (%) 
Most common Obesity (57) Hypertension (51) Hypertension (43) Hypertension (29) Hypertension (28) Hypertension (15) Obesity (35) 
2nd most common Hypertension (38) Obesity (43) Obesity (27) Obesity (24) Obesity (26) Obesity (15) Hypertension (32) 
3rd most common HIV (26) Asthma/COPD (10) HIV (15) HIV (18) Diabetes (8) HIV (13) HIV (16) 
4th most common Diabetes (10) Diabetes (8) Tuberculosis (8) Diabetes (4) Heart disease (5) Diabetes (4) Diabetes (7) 
5th most common Tuberculosis (7) Heart disease (7) Asthma/COPD (7) Asthma/COPD (4) HIV (3) Asthma/COPD (2) Asthma/COPD (4) 
6th most common Asthma/COPD (4) HIV (2) Diabetes (6) Tuberculosis (3) Asthma/COPD (3) Heart disease (2) Tuberculosis (4) 
7th most common Heart disease (2) Tuberculosis (1) Heart disease (5) Heart disease (1) Tuberculosis (0) Tuberculosis (1) Heart disease (3) 
Chronic conditions N positive (% positive) 
      
Obese 410 (56.9) 43 (43.4) 104 (27.4) 45 (24.1) 98 (25.7) 62 (14.7) 762 (34.8) 
Hypertension 271 (37.6) 50 (50.5) 161 (42.5) 54 (28.9) 105 (27.5) 63 (14.9) 704 (32.2) 
HIV 187 (26) 2 (2.0) 56 (14.8) 34 (18.2) 13 (3.4) 56 (13.3) 348 (15.9) 
Diabetes 69 (9.6) 8 (8.1) 21 (5.5) 7 (3.7) 31 (8.1) 17 (4.0) 153 (7.0) 
Asthma/COPD 25 (3.5) 10 (10.1) 27 (7.1) 7 (3.7) 11 (2.9) 10 (2.4) 90 (4.1) 
Tuberculosis 48 (6.7) 1 (1.0) 29 (7.7) 6 (3.2) 0 (0.0) 3 (0.7) 87 (4.0) 
Heart disease 13 (1.8) 7 (7.1) 17 (4.5) 1 (0.5) 18 (4.7) 8 (1.9) 64 (2.9) 
Any chronic condition 617 (85.7) 73 (73.7) 256 (67.5) 114 (61) 193 (50.5) 163 (38.6) 1416 (64.7) 
Number of pre-existing 
chronic conditions 
       
0 103 (14.3) 26 (26.3) 123 (32.5) 73 (39.0) 189 (49.5) 259 (61.4) 773 (35.3) 
1 315 (43.8) 37 (37.4) 141 (37.2) 79 (42.2) 130 (34) 115 (27.3) 817 (37.3) 
2 210 (29.2) 26 (26.3) 80 (21.1) 31 (16.6) 47 (12.3) 41 (9.7) 435 (19.9) 
3 82 (11.4) 8 (8.1) 28 (7.4) 3 (1.6) 12 (3.1) 6 (1.4) 139 (6.3) 
4+ 10 (1.4) 2 (2.0) 7 (1.8) 1 (0.5) 4 (1.0) 1 (0.2) 25 (1.1) 
Multimorbidity (≥2) 302 (41.9) 36 (36.4) 115 (30.3) 35 (18.7) 63 (16.5) 48 (11.4) 599 7.4) 
• MICs (Middle income countries), LIC (Low income countries), COPD (Chronic obstructive pulmonary disease),  
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Table 3: Associations of socio-demographic characteristics with each chronic conditions, among breast cancer patients in Sub-Saharan Africa, ABC-
DO study. ORs are mutually adjusted. 
 
 Non-communicable diseases Communicable diseases  
Socio-demographic 
characteristics 
Obesity (BMI ≥ 
30.0 kg/m2) 
Hypertension Diabetes Asthma/COPD Heart disease HIV positive Tuberculosis NCDs combined 
 
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Age (10 year increase) 1.09 (1.01-1.18)a 1.98 (1.81-2.17)b 1.51 (1.32-1.74)b 1.08 (0.91-1.29) 1.69 (1.37-2.09)b 0.64 (0.58-0.71)b 0.97 (0.81-1.15) 1.62 (1.50-1.76)b 
Marital status 
 
       
Not married 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 
Married 1.25 (1.02-1.54)a 1.07 (0.87-1.33) 1.39 (0.97-2.00)  0.90 (0.57-1.42) 0.80 (0.45-1.43) 0.51 (0.39-0.67)b 0.62 (0.36-1.03) 1.02 (0.84-1.25) 
Highest level of education         
Primary education and 
below 
1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 
Secondary education and 
above 
1.01 (0.79-1.29) 1.05 (0.82-1.36) 0.77 (0.51-1.16) 1.03 (0.60-1.77) 1.06 (0.56-2.02) 1.18 (0.86-1.61) 1.13 (0.65-1.97) 1.04 (0.82-1.33) 
Employment status         
Unemployed 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 
Employed 1.51 (1.17-1.97)a 0.98 (0.74-1.29) 1.11 (0.68-1.82) 1.16 (0.62-2.16) 0.71 (0.32-1.56) 0.88 (0.65-1.18) 0.90 (0.51-1.59) 1.22 (0.95-1.58) 
SEP         
Low (0-3) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 
Medium (4-6) 1.93 (1.54-2.40)b 1.20 (0.95-1.51) 1.77 (1.16-2.69)a 1.85 (1.09-3.15)a 1.08 (0.58-1.99) 0.60 (0.46-0.79)b 1.35 (0.83-2.20) 1.76 (1.42-2.18)b 
High (7-9) 3.05 (2.22-4.18)b 1.86 (1.33-2.59)b 3.25 (1.88-5.62)b 1.74 (0.86-3.51) 1.59 (0.72-3.52) 0.65 (0.41-1.02) 1.26 (0.55-2.86) 2.75 (2.02-3.75)b 
Country          
Uganda 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 
Namibia Black 1.93 (1.34-2.78)b 3.76 (2.61-5.41)b 1.06 (0.54-2.09) 2.71 (1.28-5.76)a 1.84 (0.76-4.45) 1.27 (0.84-1.94) 10.61(3.18-35.46)b 2.60 (1.90-3.56)b 
Namibia Non-Black 2.26 (1.35-3.77)a 2.98 (1.73-5.12)b 0.89 (0.35-2.27) 3.11 (1.17-8.29) b 2.30 (0.71-7.46) 0.25 (0.10-1.07) 1.30 (0.13-13.08) 2.94 (1.72-5.01)b 
Nigeria 1.73 (1.19-2.51)a 2.26 (1.54-3.32)b 1.98 (1.04-3.76)a 1.09 (0.44-2.66) 2.82 (1.15-6.90)a 0.27 (0.14-0.50)b Omitted 2.23 (1.62-3.08)b 
South Africa 9.68 (6.65-14.07)b 2.67 (1.82-3.92)b 2.32 (1.19-4.55)a 1.29 (0.54-3.06) 0.53 (0.18-1.57) 2.72 (1.82-4.08)b 8.10 (2.33-28.12)a 6.13 (4.40-8.54)b 
Zambia 1.77 (1.12-2.78)a 2.11 (1.33-3.33)a 0.76 (0.30-1.91) 1.49 (0.54-4.10) 0.22 (0.03-1.79) 1.75 (1.06-2.90)a 4.38 (1.06-18.15)a 1.93 (1.30-2.86)a 
BMI (Body mass index), OR (Odds ratio), 95% CI (95% confidence interval), SEP (Socio-economic position), COPD (Chronic obstructive pulmonary disease), NCDs (Non-communicable diseases), NCDs (Obesity, 
hypertension, diabetes, asthma/COPD, heart disease), a Significant at p<0.05, b Significant at p<0.00
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Table 4: Multiple logistic regression models of chronic conditions and presence of 
multimorbidity (≥2 chronic conditions) as predictors of advanced stage breast cancer 
(stages III & IV) in women newly diagnosed with breast cancer in Sub-Saharan Africa, 
ABC-DO study. 
Chronic conditions Odds ratio 95% CI P value 
Obese   
 
No 1.00 Reference 0.049 
Yes 0.72 0.52-0.99  
Hypertension   
 
No 1.00 Reference 0.015 
Yes 0.65 0.45-0.92 
 
HIV    
Negative 1.00 Reference 0.331 
Positive 0.85 0.58-1.22  
Any chronic condition     
No 1.00 Reference 0.120 
Yes 1.30 0.92-1.84  
Multimorbidity    
< 2 chronic conditions 1.00 Reference 0.092 
≥ 2 chronic conditions 1.34 0.95-1.89  
Multiple regression model (adjusted for age, country and HIV). 
Obesity, hypertension, any chronic condition and multimorbidity were the only variables significant at p<0.01 on bivariate 









































































































































































































































































































































(C) Women 50 years
NB = Non-black



















































































































































































(A) South Africa (B) Namibia non-black
(C) Namibia black (D) Zambia
(E) Nigeria (F) Uganda
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